Navigation Links
Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv
Date:12/1/2009

NEWNAN, Ga., Dec. 1 /PRNewswire/ -- CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants, today announced that Barry Katzen, MD, FACR, FACC, FSCAI, founder and medical director of Baptist Cardiac & Vascular Institute in Miami, Florida, will discuss the CATANIA(TM) Stent System with NanoThin Polyzene®-F at the Innovations in Cardiovascular Interventions Conference to be held at the Hotel David InterContinental in Tel Aviv, Israel, which will include new information about the stent's coating, Polyzene®-F, and clinical outcomes in coronary, below-the-knee, and neurovascular applications. "We are deeply honored that Dr. Katzen will present these data at the ICI conference where innovation is recognized and celebrated. We believe the CATANIA(TM) stent is the technological breakthrough that interventional cardiologists have needed to dispense with the problems associated with bare metal and drug-eluting stents," said Thomas A. Gordy, President and chief Executive Officer of CeloNova. "Dr. Katzen is a true pioneer in interventional medicine."

(Logo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b)

(Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-a)

(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080-c)

About CeloNova BioSciences: Headquartered in Newnan, Georgia, CeloNova BioSciences, Inc., is a developer of novel medical devices that are enhanced by one of the Company's proprietary materials, Polyzene®-F, a lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant surface treatment for implanted medical devices. The Company's current products include Embozene(TM) Color-Advanced Microspheres and the CATANIA(TM) Coronary Stent System with NanoThin Polyzene®-F. Both products are CE Marked. Embozene(TM) Microspheres have been approved by the FDA for the treatment of hypervascularized tumors and arteriovenous malformations. For more information, please visit www.celonova.com.

About Innovations in Cardiovascular Interventions: The ICI meeting for interventional cardiologists, innovators, and industry will be held December 6-8, in Tel-Aviv, Israel. It is a continuation of the series of interventional cardiology conferences held in Israel since 1995. The upcoming meeting will focus on innovative technology, therapies, and research at various levels of development, with thematic live case presentations to present the impact of these technologies on current and future therapy.

Contact: Theresa Wilson +1-770-502-0304; +1-678-895-6486

SOURCE CeloNova BioSciences, Inc.


'/>"/>
SOURCE CeloNova BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Clarifying Vision - Prospects and Developments ... Care What can be expected from the ... at the fastest rates? This visiongain report ... opportunities and prospects. ,Our 190-page report ... lucrative areas in the industry and the future market ...
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016   Purdue Pharma ... into an agreement with Egalet Corporation and Acura ... As part of the agreement the companies will ... enable all three companies to develop and sell ... "This agreement reflects the commitment of Purdue ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... May 24, 2016 , ... Mental health watchdog ... the Church of Scientology and renowned professor of psychiatry Thomas Szasz, is continuing its ... “Psychiatry: An Industry of Death” exhibit in Atlanta, Georgia. The opening of the exhibit ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health ... adult hospital and expanded Children’s Hospital. Over 3,000 people looked on as the shovels ... out the event photo slidehsow. , During the program, Richard H. Hart, MD, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed ... data logger for each job, ensuring the best suited solution to meet regulatory ... data loggers at their lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Growing in ... growing trend, more gluten-free products are available and easily accessible. Whether someone chooses to ... to cater to a certain diet, King Kullen Grocery stocks their shelves with many ...
(Date:5/24/2016)... ... May 24, 2016 , ... The ... 9.3 million people, or 10% over last year, according to data in the ... group policies was comparatively stable, with a slight decrease in risk-based groups and ...
Breaking Medicine News(10 mins):